Comparación del VPP y del VTI del TSVI durante la elevación pasiva de piernas para predecir la respuesta a fluidos
Comparación de la Variación de la Presión del Pulso y los Cambios del Gasto Cardíaco Basados en el VTI del TSVI Durante la Maniobra de Elevación Pasiva de las Piernas para Predecir la Respuesta a la Fluidoterapia en Pacientes Críticos con Ventilación Mecánica: Un Estudio Observacional Prospectivo
Hemodynamic instability remains one of the leading causes of morbidity and mortality among critically ill patients in intensive care units. One major contributor to this instability is intravascular fluid deficit. Although fluid administration is often preferred as an initial intervention, inaccurate estimation of fluid requirements carries significant risks. Inadequate resuscitation may lead to tissue hypoperfusion and organ dysfunction, whereas excessive fluid loading is associated with pulmonary edema, increased intra-abdominal pressure, multi-organ dysfunction, and increased mortality. Consequently, reliable prediction of fluid responsiveness is considered a critical determinant in modern intensive care management.
The limited reliability of static parameters in predicting fluid responsiveness and the fact that PPV retains its validity only under specific clinical conditions highlight the need for more effective methods. In recent years, hemodynamic changes assessed during the passive leg raising (PLR) maneuver have gained prominence; particularly, left ventricular outflow tract velocity time integral (LVOT VTI)-based cardiac output measurements have been identified as a strong parameter for predicting fluid responsiveness . Moreover, changes in pulse pressure variation (PPV) during PLR have also been reported as a potential predictor; however, the number of studies prospectively comparing PPV variation and LVOT VTI-based cardiac output change within the same patient population remains limited . Therefore, the proposed study aims to fill this gap in the literature and contribute to fluid management in the intensive care setting.
The aim of this study is to compare the performance of PPV variation and LVOT VTI-based cardiac output change after the PLR maneuver in predicting fluid responsiveness among mechanically ventilated critically ill patients, and to determine the diagnostic value of both methods. The findings of the present study are expected to support more reliable decision-making in fluid therapy and provide clinical evidence toward the individualization of fluid management in intensive care practice.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Descripción detallada
This study is designed as a prospective observational trial. No additional intervention, procedure, or treatment beyond standard clinical practice will be performed. All data will be obtained during routine clinical management in our intensive care unit.
In mechanically ventilated patients with suspected fluid deficit, the passive leg raising (PLR) maneuver is applied as part of standard practice, during which changes in pulse pressure variation (PPV) are recorded by invasive arterial monitoring.
In this observational study, transthoracic echocardiographic (TTE) measurements of LVOT VTI will be performed by an experienced operator in addition to routine practice. Using pulse wave Doppler (PW), LVOT VTI will be recorded, and stroke volume (SV) and cardiac output (CO) will be calculated by multiplying the LVOT VTI value by the LVOT diameter. Consequently, changes in PPV and LVOT VTI-based CO during PLR will be compared.
Following TTE measurements of LVOT VTI and LVOT diameter in both the semi-recumbent position (45°) and immediately after PLR, SV and CO will be calculated. Based on these measurements, patients will be allocated into two groups:
- Fluid responsive: Patients showing ≥10% increase in LVOT VTI-based CO following PLR
- Non-fluid responsive: Patients showing <10% change in LVOT VTI-based CO following PLR
After grouping patients accordingly, PPV changes during PLR will be compared between the two groups. This will allow evaluation of the predictive performance of PPV variation relative to LVOT VTI-based CO change in determining fluid responsiveness. All measurements will be performed by an experienced clinician without disrupting standard patient care. No additional fluid loading, invasive procedures, or therapeutic interventions will be undertaken throughout the study.
The primary aim is to compare the diagnostic performance of PPV variation and LVOT VTI-based cardiac output changes following a PLR maneuver in predicting fluid responsiveness. The study seeks to determine the diagnostic value of both methods to support more individualised fluid management.
The recorded data will include:
- Pre- and post-PLR LVOT VTI, stroke volume, cardiac output, and PPV values
- Routine monitoring parameters (systolic/diastolic blood pressure, mean arterial pressure, heart rate, and SpO₂)
- Demographic characteristics (age, sex, comorbidities) retrieved through the hospital database
Informed consent will be obtained from all participating patients or their legally authorized representatives.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Ahmet Salih Tüzen, M.D.
- Número de teléfono: +90 535 391 55 77
- Correo electrónico: astuzen@icloud.com
Copia de seguridad de contactos de estudio
- Nombre: Murat Aksun, M.D.
- Número de teléfono: +90 552 363 16 14
- Correo electrónico: murataksun@yahoo.com
Ubicaciones de estudio
-
-
-
Izmir, Turquía (Türkiye)
- Reclutamiento
- Izmir Katip Celebi University Atatürk Training and Research Hospital İzmir, , Turkey
-
Contacto:
- Elif Ersüs, M.D.
- Número de teléfono: +90 537 944 60 59
- Correo electrónico: elifersus@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
The study population consists of adult critically ill patients admitted to the Intensive Care Unit (ICU) who are receiving mechanical ventilation support. Eligible participants are those identified by the intensive care team as having a suspected intravascular fluid deficit, for whom a fluid responsiveness assessment is clinically indicated. The cohort specifically targets patients undergoing the Passive Leg Raising (PLR) maneuver as part of routine standard practice, where invasive arterial monitoring is available to record Pulse Pressure Variation (PPV).
Descripción
Inclusion Criteria:
- Adult patients aged ≥18 years
- Patients admitted to the intensive care unit receiving mechanical ventilation
- Presence of suspected intravascular fluid deficit (hypotension, negative fluid balance, or clinical signs of peripheral hypoperfusion)
- Patients in sinus rhythm
- Presence of invasive arterial blood pressure monitoring
- Adequate echocardiographic window allowing transthoracic echocardiographic measurement of LVOT VTI
- Patients ventilated with tidal volume ≥8 mL/kg (ideal body weight)
- Hemodynamically stable enough to allow measurement
Exclusion Criteria:
- Patients under 18 years of age
- Presence of atrial fibrillation or significant arrhythmias such as frequent ventricular or atrial ectopy
- Severe right ventricular dysfunction or significant tricuspid regurgitation
- Advanced aortic valve disease (severe stenosis or severe regurgitation)
- Patients with significant spontaneous breathing effort
- Patients receiving lung-protective low tidal volume ventilation strategy (<8 mL/kg) due to ARDS
- Inadequate echocardiographic window for LVOT VTI assessment
- Severe hemodynamic instability during measurement (sudden vasopressor escalation or need for resuscitation)
- Patients who refuse to participate or from whom written informed consent cannot be obtained from themselves or a first-degree relative
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
|---|
|
Fluid Responders
Defined as an increase in LVOT VTI-based Cardiac Output (CO) of ≥ 10% from baseline. |
|
Fluid Non-Responders
Defined as an increase in LVOT VTI-based Cardiac Output (CO) of < 10% from baseline. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Pulse Pressure Variation (Delta PPV)
Periodo de tiempo: Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Pulse Pressure Variation (PPV) is recorded via invasive arterial monitoring at baseline (T0, semi-sitting) and during the Passive Leg Raising maneuver (T1). |
Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Percentage Change in Cardiac Output (Delta CO)
Periodo de tiempo: Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Cardiac Output (CO) is calculated using the Left Ventricular Outflow Tract Velocity Time Integral (LVOT VTI) and the LVOT diameter measured via transthoracic echocardiography. |
Baseline (T0) and between 60 seconds after the PLR maneuver.
|
|
Correlation between Delta PPV and Delta CO
Periodo de tiempo: Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Correlation Coefficient (r) between PPV Change and Cardiac Output Change |
Baseline (T0) and between 60 seconds after the PLR maneuver.
|
|
Hemodynamic Parameter Changes (MAP, HR)
Periodo de tiempo: Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Measurement of changes in mean arterial pressure and heart rate before and after PLR and comparison between groups. |
Baseline (T0) and between 60 seconds after the PLR maneuver.
|
|
Diagnostic Accuracy (ROC-AUC, Sensitivity, Specificity, Cut-off)
Periodo de tiempo: Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Evaluation of diagnostic performance of ΔPPV and ΔCO using receiver operating characteristic (ROC) analysis, including AUC, optimal cut-off value, sensitivity, and specificity for predicting fluid responsiveness. |
Baseline (T0) and between 60 seconds after the PLR maneuver.
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Murat Aksun, Izmir Katip Celebi University Atatürk Training and Research Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- 2025-SAEK-0811
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
All data necessary to support the study protocol, including de-identified individual participant data (IPD) related to study protocol, and primary and secondary outcome measures, will be made available upon reasonable request from qualified researchers for academic purposes, in accordance with institutional and ethical guidelines.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .